FMDGX | PMBMX | FMDGX / PMBMX | |
Total Expense Ratio | 0.05 | 1.14 | 4% |
Annual Report Gross Expense Ratio | 0.05 | 1.14 | 4% |
Fund Existence | 6 years | 25 years | - |
Gain YTD | 5.474 | 1.787 | 306% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.53B | 30.6B | 8% |
Annual Yield % from dividends | 0.44 | 0.02 | 2,018% |
Returns for 1 year | 21.91 | 9.71 | 226% |
Returns for 3 years | 75.90 | 47.38 | 160% |
Returns for 5 years | 70.02 | 50.58 | 138% |
Returns for 10 years | N/A | 83.54 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.06 | -0.09 | -0.47% |
Saratoga Health & Biotechnology A | |||
PGOFX | 49.79 | -0.56 | -1.11% |
Victory Pioneer Select Mid Cap Growth A | |||
DEMIX | 24.56 | -0.29 | -1.17% |
Macquarie Emerging Markets Instl | |||
VREMX | 8.23 | -0.10 | -1.20% |
Virtus SGA Emerging Markets Equity R6 | |||
ALGCX | 16.74 | -0.24 | -1.41% |
Alger International Opportunities C |